Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Docetaxel on a Bi-Weekly Schedule in the Treatment of Elderly Men With Hormone-Refractory Prostate Cancer (HRPC)

NCT00215709 is registered in ClinicalTrials.gov with Geriatric Oncology Consortium as lead sponsor.

NCT NCT00215709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00215709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Docetaxel on a Bi-Weekly Schedule in the Treatment of Elderly Men With Hormone-Refractory Prostate Cancer (HRPC)
Lead sponsor
Geriatric Oncology Consortium
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2004
Completion date
July 31, 2007
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer